Health and Safety is an issue that effects all businesses, large or small and irrespective of the type of
business they carry out. A recent case involving a Sheffield based firm serves as a stark reminder as
to the potentially disastrous results should a company fall foul of the relevant regulations.
Pursuant to Rule 12.12 of the Committee of Advertising Practice, botulinum toxin injections (like Botox) are categorised as prescription only medicines and therefore cannot be advertised to the public (not even by a registered medical professional).
This time last year many businesses were introducing new policies and training their staff, in readiness for the GDPR coming into effect on 25th May 2018.
New regulations set to come into force in summer 2018 will allow company Directors and individuals to remove details of their residential address filed on the public register at Companies House.
Currently under the Companies Act 2006, company Directors and Secretaries are able to provide a service address for correspondence to ensure that their residential address is not shown on the public register. Whilst the 2006 Act allowed a service address to be provided it did not provide for the removal of any existing residential addresses that had previously been filed at Companies House.
